Week Ending: 14 August 2026

Taiwan TW Healthcare Industry

Medical Instruments & Supplies

For the week ending 14 August 2026, Medical Instruments & Supplies declined 1.27% with 1 advancing, 7 declining, and 0 unchanged constituents. The index is equal weighted and the constituent tape shows uncapped security returns.

Current architecture Balance

Directional pressure is compressed and neither side has durable control.

47 technical evidence

Index2221.78 1 week-1.27% Breadth13% Members8

Country 🇹🇼 Taiwan · TW

Sector Healthcare

Universe country-listed

Price basis Adjusted weekly close

Trend architecture

Index, activity fan and structural anchors

Rolling 156-week evidence. Trend Signal points mark weeks when price, trend and the activity fan confirmed together.

Index Value Trend Line Fair Value Activity Lines Constructive architecture Transitional architecture Defensive architecture

Current architecture Balance 2 completed weeks in this state

Trend acceptance 2.2% Index versus Trend Line

Persistence 50% Negative regime, shorter trend repairing

Participation 13% 1 advancing, 7 declining

Investor positioning lens

Is the evidence ready for capital?

A rules-based technical classification using trend, breadth, persistence, relative strength and path quality.

Current posture Reduce exposure into strength

Counter-trend rallies may occur, but primary structure and persistence do not yet support adding risk.

47 technical evidence
out of 100

Evidence balance

Five-pillar map

Reduce

Trend

Breadth

Persistence

Relative

Risk quality

What supports the view

Constituent trends show positive multi-horizon persistence.

What restrains conviction

Index trend architecture has not delivered a durable upward expansion.
Breadth remains too narrow or inconsistent for a high-conviction position.
The group is not yet delivering dependable relative outperformance.
Positive contribution is concentrated in a small leadership cohort.

Independent sentiment overlay Sentiment held separate

Qualified news coverage is too thin to alter the technical positioning view.

Evidence that would change the view

A completed weekly reclaim of 2,379.77, the higher of Trend Line and Fair Value, would improve the structural case.
Breadth holding above 55% for several completed weeks would show that repair is spreading.
Positive 13 and 26-week relative performance would confirm that capital is rotating into the group.

This is a weekly research classification, not personal investment advice. Sentiment is reported as an independent confirmation layer and does not alter the technical score.

Trend state and durability

Architecture, persistence and constituent regimes

The index path is tested against the underlying security-level trend evidence.

Index architecture Balance

Directional pressure is compressed and neither side has durable control.

State age2 weeks

Trend gateMixed

Fan width0.93%

Fast versus slow change0.21 pts

Above 50% Below 50%

Six completed weeks of price acceptance relative to the full Activity Line fan.

Index persistence

Negative regime, shorter trend repairing

50% agreement

The long trend remains negative, but shorter-horizon repair is now visible.

13-week

6.3%

26-week

2.8%

39-week

-2.6%

52-week

-4.1%

Regime age5 weeks 52-week flips4 52-week boundary2317.94

Constituent trend persistence

Is the index move broadly durable?

100% coverage

50%positive

Coherent positive38%

Coherent negative12%

Average horizon agreement88%

Positive horizon share56%

Weakening positives0

Repairing negatives2

8 constituents measured as of 14 Aug 2026. Median trend age is 14 weeks.

Custom stage map

Where constituents sit in the cycle

Stage Analysis coverage is still building.

Capital rotation

Performance relative to Healthcare

Improving

Relative index 13-week relative trend Starting level

Rotation dashboard Improving

A rising relative line means this group is compounding faster than Healthcare. A falling line means capital has done better in the parent benchmark.

Relative index96.4

13-week trend94.4

4-week trend change0.99%

Weekly peer rank5 of 5

1 week

-1.6 pts relative

4 weeks

3.8 pts relative

13 weeks

3.4 pts relative

26 weeks

7.6 pts relative

52 weeks

-4.9 pts relative

Market internals

Participation, dispersion and path risk

Equal-weight index evidence with constituent-level breadth and dispersion.

Breadth

Participation quality

Narrow

13% advanced

Advancing: 1
Declining: 7
Unchanged: 0

4-week average 41%

13-week average 45%

Risk and persistence

Path quality

52-week lens

Annualised weekly volatility16.1%

Drawdown from 52-week high-5.8%

Positive weeks, last 1331%

Current directional run1 week

Turnover versus 13-week norm53%

Breadth impulse-35.4 pts

Cross-section

Return distribution

8 measured

Q1 -2.2% Median -0.8% Q3 -0.2%

Average winner3.5%

Average loser-1.9%

Dispersion2.8 pts

Top-five upside share100%

Top-five capital share86%

Capital data coverage100%

Dispersion describes how far constituent outcomes are spreading apart. Capital concentration is contextual only; the index itself is equal weighted.

Momentum cycle

30-week persistence

Positive readings show expansion. Negative readings show contraction.

Breadth cycle

Net participation

Advancers less decliners as a percentage of measured constituents.

News and narrative

Does company news confirm the market tape?

Open Sentiment Intelligence

Sentiment evidence is still developing

Qualified company-level news coverage is not yet broad enough to influence the group view.

0 qualified records across 8 measured constituents.

Leadership tape

Leaders, laggards and contribution shape

Latest completed week, ranked on uncapped constituent returns.

Leading edge

1 4737Bionime Corporation

3.45% 2 1752Nang Kuang Pharmaceutical Co., Ltd.

-0.16% 3 1783Maxigen Biotech Inc.

-0.25% 4 1786SciVision Biotech Inc.

-0.50% 5 6491Pegavision Corporation

-1.07%

Weakest edge

8 6782Visco Vision Inc.

-7.11% 7 9103Medtecs International Corporation Limited

-2.27% 6 4771Vizionfocus Inc.

-2.22% 5 6491Pegavision Corporation

-1.07% 4 1786SciVision Biotech Inc.

-0.50%

Constituent ledger

Industry constituents

All 8 measured constituents, ranked by latest weekly return.

Rank Ticker Company Exchange Market cap Close Index contribution Return

1 4737 Bionime Corporation TAI 4.40B 56.90 0.43 pts

3.45%

2 1752 Nang Kuang Pharmaceutical Co., Ltd. TAI 3.23B 31.95 -0.02 pts

-0.16%

3 1783 Maxigen Biotech Inc. TAI 3.61B 40.30 -0.03 pts

-0.25%

4 1786 SciVision Biotech Inc. TAI 3.60B 49.55 -0.06 pts

-0.50%

5 6491 Pegavision Corporation TAI 28.35B 369.00 -0.13 pts

-1.07%

6 4771 Vizionfocus Inc. TAI 11.62B 198.00 -0.28 pts

-2.22%

7 9103 Medtecs International Corporation Limited TAI 2.81B 5.16 -0.28 pts

-2.27%

8 6782 Visco Vision Inc. TAI 12.76B 202.50 -0.89 pts

-7.11%

The index uses capped equal-weight weekly constituent returns. The ledger shows uncapped security returns so outliers remain visible for research.